Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ilesol Pharmaceuticals is a European contract manufacturer and supplier specializing in the production of high-quality cannabinoid-based ingredients and finished products. Based in Croatia, the company operates a GMP-certified facility dedicated to the extraction, distillation, and isolation of compounds from industrial hemp, such as CBD, CBG, and CBN. Ilesol provides a range of services including white-labeling, private labeling, and custom formulation for the pharmaceutical, cosmetic, and nutraceutical sectors. Their technical capabilities include advanced chromatography and supercritical CO2 extraction, ensuring high purity and compliance with international standards. The company serves a global clientele, providing standardized raw materials and bulk ingredients for diverse health and wellness applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ilesol Pharmaceuticals.